Cardiometabolic Diseases Market—Trends and Growth Opportunities, Forecast to 2022

Shift Towards a 'Comprehensive Care Continuum' with the Adoption of Integrated Care Pathways that Combine Clinical Therapies with Wellness Programs

USD 4,950.00

* Required Fields

USD 4,950.00

PAY BY INVOICE

Be the first to review this product

This is a premium access report. To purchase click on the buy now button. Use code: FROSTCMHC60 to access our promotional pricingGlobally, cardiometabolic diseases are witnessing a consistent rise in prevalence every year, with hypertension and diabetes among the leading conditions. A rising population of hypertension is, in turn, leading to growing incidence of chronic heart failure with about 26 million cases of CHF globally. Although drug therapies are the first line of treatment in cases of CHF, hypertension, and diabetes, obesity treatment requires a mixture of nutritional, behavioral, and drug therapies, wherein drugs act as an adjunct to the behavioral therapies. With the growing number of cardiometaboli

Research Scope

The present study aims at identifying some of the key growth opportunities, which are set to drive the market in the next few years. Additionally, the study also identifies the most prevalent and emerging business models across the market, which are supporting industry stakeholders in enhancing their geographic coverage in terms of patient outreach and address challenges of inadequate patient access. The study provides in-depth revenue and market analysis of 4 key markets, chronic heart failure (CHF), hypertension, diabetes, and obesity. The study also highlights some of the key market drivers and restraints that affect the growth. It gives an overview of the competitive environment providing brief insights on some of the game-changing participants across each segment that are working toward developing disruptive technologies and drugs, thus maintaining their growth trajectory. Focus is also given on some of the leading M&A activities impacting the market as well as present and future market trends that would shape the market.


Key Issues Addressed

  • How is the market attractiveness for cardiometabolic therapeutics evolving over the years? What is the future market potential?
  • What is the role played by primary and community care in management of cardiometabolic diseases?
  • What are the current and future trends impacting the market growth? What are the emerging business models set to transform the market landscape?
  • What are the key regulatory and pricing changes across the cardiometabolic market? How are these changes expected to affect the market in the long run?
  • What are the major growth opportunities across the cardiometabolic diseases market? What kind of impact would these have on the market growth?
  • What are the applications of emerging technologies and digital transformation on the overall market? How is it expected to impact the market in the next few years?

Table of Contents

Executive SummaryKey FindingsKey Findings (continued)Scope and SegmentationKey Questions to be AnsweredMarket Engineering MeasurementsMarket Engineering Measurements (continued)Market Engineering Measurements (continued)Market Engineering Measurements (continued)CEO’s PerspectiveBig Market ThemesExecutive Summary—3 Big PredictionsMarket OverviewMarket Segmentation Key Trends and Impact on the MarketCardiometabolic Diseases—Value Chain AnalysisImpact of Regulatory and Pricing PoliciesVBP Models—Impact AnalysisCompetitive PlaybookDisruptive Market ParticipantsNew Market OpportunitiesNew Market Opportunities (continued)Merger, Acquisition, and Partnership AssessmentMerger, Acquisition, and Partnership Assessment (continued)Drivers, Restraints, and Trends—Total Cardiometabolic Diseases MarketMarket DriversDrivers ExplainedDrivers Explained (continued)Market RestraintsRestraints ExplainedRestraints Explained (continued)Forecasts and Trends—Total Cardiometabolic Diseases MarketMarket SummaryMethodology and Forecast AssumptionsRevenue Forecast by SegmentRevenue Forecast DiscussionSegment Analysis—Chronic/Congestive Heart Failure Key Segment FindingsKey Segment Findings (continued)Key Segment Findings (continued)Market Engineering MeasurementsRevenue ForecastRevenue Forecast DiscussionGlobal Market Share AnalysisCompetitive Landscape—Pipeline AnalysisKey Companies to Watch Segment Analysis—HypertensionKey Segment Findings Key Segment Findings (continued)Key Segment Findings (continued)Market Engineering MeasurementsRevenue ForecastRevenue Forecast DiscussionGlobal Market Share AnalysisCompetitive Landscape—Pipeline AnalysisKey Companies to WatchSegment Analysis—Type II DiabetesKey Segment Findings Key Segment Findings (continued)Key Segment Findings (continued)Market Engineering MeasurementsRevenue ForecastRevenue Forecast DiscussionGlobal Market Share AnalysisCompetitive Landscape—Pipeline AnalysisKey Companies to Watch Segment Analysis—ObesityKey Segment FindingsKey Segment Findings (continued)Key Segment Findings (continued)Market Engineering MeasurementsRevenue ForecastRevenue Forecast DiscussionGlobal Market Share AnalysisCompetitive Landscape—Pipeline AnalysisKey Companies to Watch Future of Cardiometabolic Diseases MarketKey Future Trends for Cardiometabolic Diseases Market Growth Opportunities and Companies to ActionTransformation in Cardiometabolic Industry Ecosystem—20175 Major Growth Opportunities Growth Opportunity Impact AnalysisGrowth Opportunity 1—Enhanced Patient Engagement Through Digital TherapeuticsGrowth Opportunity 2—Clinical Support leveraged Through AIGrowth Opportunity 3—Innovative Drug Delivery Technologies for Better Drug EfficacyGrowth Opportunity 4—Regenerative Medicine for Novel Curative TherapiesGrowth Opportunity 5—Leveraging Biomarkers for Risk Assessment and Disease DiagnosisStrategic Imperatives for Success and Growth The Last Word3 Big PredictionsLegal DisclaimerCardiometabolic Health Congress (CMHC)AppendixList of ExhibitsList of Exhibits (continued)List of Exhibits (continued)Merger, Acquisition, and Partnership AssessmentMerger, Acquisition, and Partnership Assessment (continued)AbbreviationsMarket Engineering Methodology

Infographic





Related Research

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.